|
Volumn 6, Issue 3, 2001, Pages 258-259
|
Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders [2]
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE;
MIRTAZAPINE;
SEROTONIN UPTAKE INHIBITOR;
SUBSTANCE P;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ADULT;
AFFECTIVE NEUROSIS;
AGED;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG RESPONSE;
ELECTROCONVULSIVE THERAPY;
FEMALE;
GENE DELETION;
GENE INSERTION;
GENETIC POLYMORPHISM;
GENOTYPE;
HAMILTON SCALE;
HOMOZYGOSITY;
HOSPITALIZATION;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
TRANSCRANIAL MAGNETIC STIMULATION;
ADULT;
AGED;
AGED, 80 AND OVER;
FEMALE;
GENE DELETION;
HUMANS;
MALE;
MIDDLE AGED;
MOOD DISORDERS;
PEPTIDYL-DIPEPTIDASE A;
POLYMORPHISM, GENETIC;
|
EID: 0035056928
PISSN: 13594184
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.mp.4000857 Document Type: Letter |
Times cited : (81)
|
References (10)
|